The VentureMed Group

In 2012, practicing vascular surgeon, John P. Pigott, MD, FACS realized there was an unmet need in vessel preparation for the treatment of peripheral artery disease (PAD). With support from Promedica Innovations, Dr. Pigott founded the VentureMed Group to design, develop, and market cost-effective interventional devices to improve patient outcomes and reduce the overall cost of care for the provider and the procedure.

VentureMed Group, Inc is pleased to be a member of the Promedica Innovations Incubator in Toledo, Ohio - a state-of-the-art medical device development and commercialization center.

VentureMed Group has received ISO 13485 Certification for its Quality System.

Management Team

John P. Pigott, MD

Founder, Chief Science Officer

John P. Pigott, MD, FACS, is the founder and chief science officer of VentureMed Group. He is the past director of endovascular surgery at the Jobst Vascular Institute and current Chief Innovation Officer for ProMedica Health Systems in Toledo, Ohio. Dr. Pigott previously completed a fellowship in vascular surgery at the Mayo Clinic. With more than 50 peer-reviewed publications and presentations to his credit, he has spent more than 20 years in the endovascular arena.

J. Robert Paulson, Jr.

President, Chief Executive Officer

Bob is president, chief executive officer and a director of the VentureMed Group. Bob has more than twenty-three years of medical device leadership experience, including serving as president, CEO and a director at NxThera and Restore Medical, and in a variety of executive leadership roles at Endocardial Solutions, Advanced Bionics and Medtronic. Prior to joining the medical device industry, Bob held a variety of senior marketing, business development, legal and finance positions at General Mills, and as an attorney with the law firm of Lindquist & Vennum. Bob currently serves as a director of Veran Medical Technologies and Spineology, is vice chair of the Luther College Board of Regents and previously served as a director on the boards of several public and privately-held medical device companies and charitable foundations. Bob received a JD from the Vanderbilt University School of Law, an MBA from the University of St. Thomas, and a BA from Luther College, with majors in Accounting, Economics and Political Science.

Gary Smith

Member of Leadership Team

Gary is a member of the VentureMed Group leadership team. He brings thirty years of business leadership experience in the medical device, equipment and diagnostics industry to the company. He led each of the VentureMed Group, IR Diagnostyx, PrognostiX, and CleveX from concept through commercialization. Gary also served in senior leadership roles at BioOhio and Battelle and is on the Advisory Board at SIMnext. Gary received an MBA from the Fox School of Business at Temple University, a BS in Physiology from the University of Toledo, and PhD Candidate, Cardiovascular Physiology from the Medical College of Ohio.

Dave Cox

VP of Sales and Marketing

Dave Cox has over 25 years of experience in medical device and biotech pharmaceutical sales and sales management including 19 years in the endovascular device space. From 2013 to 2016, Dave was Vice President of Sales, Sales Operations and Sales Training for Covidien's peripheral teams leading both the endo-arterial and endo-venous businesses. In 2016, post buy-out, he strategically guided the ev3 peripheral portfolios from Covidien to Medtronic. Over his career Mr. Cox has led expansions of sales teams, integrations post company mergers, and launched new innovative technologies and key product portfolio extensions. Previously he served as Regional Sales Manager, Area Director of Sales, and Senior Director of Corporate Accounts for Covidien, ev3, and Microvena. He holds a BBA in Business Administration from James Madison University.

Follow Us: